{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62856-215",
      "generic_name": "lecanemab",
      "labeler_name": "Eisai Inc.",
      "brand_name": "LEQEMBI",
      "active_ingredients": [
        {
          "name": "LECANEMAB",
          "strength": "100 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "62856-215-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (62856-215-01)  / 5 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20230106",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Eisai Inc."
        ],
        "rxcui": [
          "2626147",
          "2626153",
          "2626155",
          "2626156",
          "2723406",
          "2747782"
        ],
        "spl_set_id": [
          "9d1ff786-e577-410a-a273-c4d7d0e4e975"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0362856222105"
        ],
        "nui": [
          "N0000193951",
          "N0000193950"
        ],
        "pharm_class_epc": [
          "Amyloid Beta-directed Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "Amyloid Beta-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "12PYH0FTU9"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "5bf59fb4-34d6-40dd-9061-a74173f14f58",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20230106",
      "product_id": "62856-215_5bf59fb4-34d6-40dd-9061-a74173f14f58",
      "application_number": "BLA761269",
      "brand_name_base": "LEQEMBI",
      "pharm_class": [
        "Amyloid Beta-directed Antibody Interactions [MoA]",
        "Amyloid Beta-directed Antibody [EPC]"
      ]
    }
  ]
}